Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase‐4 inhibitor vildagliptin

A 69‐year‐old man started taking the dipeptidyl peptidase‐4 inhibitor, vildagliptin. One week later, C‐reactive protein and plasma immunoglobulin E levels were markedly elevated, and the vildagliptin was stopped. After the patient's laboratory findings were normalized, we decided to restart vil...

Full description

Saved in:
Bibliographic Details
Published in:J Diabetes Investig
Main Authors: Anno, Takatoshi, Kaneto, Hideaki, Kawasaki, Fumiko, Shigemoto, Ryo, Aoyama, Yumi, Kaku, Kohei, Okimoto, Niro
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319481/
https://ncbi.nlm.nih.gov/pubmed/29607626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12847
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items